RHEUMATIC DISEASES AND TUBERCULOSIS INFECTION IN CHILDREN AND ADULTS

Tuberkulez i Bolezni Lëgkih

D. A. Kudlay¹  B. E. Borodulin²  D. S. Badaeva²  E. S. Gasilina²  E. A. Borodulina²  G. V. Santalova² 

[1] Immunology Research Institute by the Russian Federal Medical Biological Agency;Samara State Medical University;

关键词: rheumatoid arthritis;    tuberculosis;    latent tuberculosis infection;    genetically engineered biologic drugs;    children;    immunologic tests;   

DOI  :  10.21292/2075-1230-2019-97-2-50-55

来源: DOAJ

【 摘 要 】

The authors summarized publications on the risk to develop tuberculosis during the treatment of rheumatic diseases with genetically engineered biologic drugs. The article describes the approaches to optimization of tuberculosis control activities in patients with rheumatic diseases: immunodiagnostics of latent tuberculosis infection and prevention of tuberculosis disease in the patients receiving genetically engineered biological drugs.

【 授权许可】

Unknown